Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer
-
By
-
Armina Saadatkhah
-
Laura Nicholson
-
Thomas A. Buchholz
-
Lee Hong
-
May 22, 2026
-
Clinical Scorecard: Exploring the Impact of Gut Microbiome on Triple-Negative Breast Cancer Beyond Tumor Dynamics
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | |
| Care Setting | Oncology, particularly in the context of chemotherapy and immunotherapy, with an emphasis on gut microbiome assessments. |
Key Highlights
- Add a highlight on the potential for microbiome-targeted interventions to improve outcomes.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Monitor treatment responses and adjust based on microbial composition and diversity, with specific assessment methods and frequency.
Risks
Patient & Prescribing Data
Incorporate gut microbiome assessments to potentially enhance treatment efficacy and detail integration into treatment plans.
Clinical Best Practices
- Evaluate gut microbiome diversity in TNBC patients and expand on monitoring strategies for dysbiosis and its clinical implications.
Related Resources & Content
